Characterization of arrhythmia substrate to ablate persistent atrial fibrillation (COAST-AF): Randomized controlled trial design and rationale.
Saved in:
| Title: | Characterization of arrhythmia substrate to ablate persistent atrial fibrillation (COAST-AF): Randomized controlled trial design and rationale. |
|---|---|
| Authors: | Nery PB; Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Canada.. Electronic address: PNery@ottawaheart.ca., Wells GA; Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Canada.; Cardiovascular Research Methods Center, University of Ottawa Heart Institute, Ottawa, Canada., Verma A; McGill University Health Center, Montreal, Quebec, Canada., Joza J; McGill University Health Center, Montreal, Quebec, Canada., Nair GM; Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Canada., Veenhuyzen G; Libin Cardiovascular Institute, University of Calgary, Calgary, Canada., Andrade J; Vancouver General Hospital, University of British Columbia,Vancouver, Canada., Nault I; Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ), Quebec City, Quebec, Canada., Wong JA; Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada., Sikkel M; Victoria Cardiac Arrhythmia Trials, Victoria, British Columbia, Canada., Essebag V; McGill University Health Center, Montreal, Quebec, Canada; Hôpital Sacré-Cœur, Université de Montréal, Montréal, Québec, Canada., Macle L; Montreal Heart Institute, Montreal, Québec, Canada., Sapp J; Queen Elizabeth II Health Sciences, Halifax, Nova Scotia, Canada., Roux JF; CHUS-Sherbrooke, Sherbrooke, Quebec, Canada., Skanes A; Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada., Angaran P; St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada., Novak P; Victoria Cardiac Arrhythmia Trials, Victoria, British Columbia, Canada., Redfearn D; Kingston General Hospital, Kingston, Ontario, Canada., Golian M; Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Canada., Redpath CJ; Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Canada., Sturmer M; Hôpital Sacré-Cœur, Université de Montréal, Montréal, Québec, Canada., Birnie D; Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Canada. |
| Source: | American heart journal [Am Heart J] 2022 Dec; Vol. 254, pp. 133-140. Date of Electronic Publication: 2022 Aug 27. |
| Publication Type: | Journal Article; Clinical Trial Protocol |
| Journal Info: | Publisher: Mosby Country of Publication: United States NLM ID: 0370465 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6744 (Electronic) Linking ISSN: 00028703 NLM ISO Abbreviation: Am Heart J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36030965 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Characterization of arrhythmia substrate to ablate persistent atrial fibrillation (COAST-AF): Randomized controlled trial design and rationale. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Nery+PB%22">Nery PB</searchLink>; Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Canada.. Electronic address: PNery@ottawaheart.ca.<br /><searchLink fieldCode="AU" term="%22Wells+GA%22">Wells GA</searchLink>; Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Canada.; Cardiovascular Research Methods Center, University of Ottawa Heart Institute, Ottawa, Canada.<br /><searchLink fieldCode="AU" term="%22Verma+A%22">Verma A</searchLink>; McGill University Health Center, Montreal, Quebec, Canada.<br /><searchLink fieldCode="AU" term="%22Joza+J%22">Joza J</searchLink>; McGill University Health Center, Montreal, Quebec, Canada.<br /><searchLink fieldCode="AU" term="%22Nair+GM%22">Nair GM</searchLink>; Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Canada.<br /><searchLink fieldCode="AU" term="%22Veenhuyzen+G%22">Veenhuyzen G</searchLink>; Libin Cardiovascular Institute, University of Calgary, Calgary, Canada.<br /><searchLink fieldCode="AU" term="%22Andrade+J%22">Andrade J</searchLink>; Vancouver General Hospital, University of British Columbia,Vancouver, Canada.<br /><searchLink fieldCode="AU" term="%22Nault+I%22">Nault I</searchLink>; Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ), Quebec City, Quebec, Canada.<br /><searchLink fieldCode="AU" term="%22Wong+JA%22">Wong JA</searchLink>; Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Sikkel+M%22">Sikkel M</searchLink>; Victoria Cardiac Arrhythmia Trials, Victoria, British Columbia, Canada.<br /><searchLink fieldCode="AU" term="%22Essebag+V%22">Essebag V</searchLink>; McGill University Health Center, Montreal, Quebec, Canada; Hôpital Sacré-Cœur, Université de Montréal, Montréal, Québec, Canada.<br /><searchLink fieldCode="AU" term="%22Macle+L%22">Macle L</searchLink>; Montreal Heart Institute, Montreal, Québec, Canada.<br /><searchLink fieldCode="AU" term="%22Sapp+J%22">Sapp J</searchLink>; Queen Elizabeth II Health Sciences, Halifax, Nova Scotia, Canada.<br /><searchLink fieldCode="AU" term="%22Roux+JF%22">Roux JF</searchLink>; CHUS-Sherbrooke, Sherbrooke, Quebec, Canada.<br /><searchLink fieldCode="AU" term="%22Skanes+A%22">Skanes A</searchLink>; Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Angaran+P%22">Angaran P</searchLink>; St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Novak+P%22">Novak P</searchLink>; Victoria Cardiac Arrhythmia Trials, Victoria, British Columbia, Canada.<br /><searchLink fieldCode="AU" term="%22Redfearn+D%22">Redfearn D</searchLink>; Kingston General Hospital, Kingston, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Golian+M%22">Golian M</searchLink>; Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Canada.<br /><searchLink fieldCode="AU" term="%22Redpath+CJ%22">Redpath CJ</searchLink>; Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Canada.<br /><searchLink fieldCode="AU" term="%22Sturmer+M%22">Sturmer M</searchLink>; Hôpital Sacré-Cœur, Université de Montréal, Montréal, Québec, Canada.<br /><searchLink fieldCode="AU" term="%22Birnie+D%22">Birnie D</searchLink>; Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Canada. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220370465%22">American heart journal</searchLink> [Am Heart J] 2022 Dec; Vol. 254, pp. 133-140. <i>Date of Electronic Publication: </i>2022 Aug 27. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Clinical Trial Protocol – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Mosby%22">Mosby </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0370465 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1097-6744 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200028703%22">00028703 </searchLink><i>NLM ISO Abbreviation: </i>Am Heart J <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36030965 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.ahj.2022.08.010 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 133 Titles: – TitleFull: Characterization of arrhythmia substrate to ablate persistent atrial fibrillation (COAST-AF): Randomized controlled trial design and rationale. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Nery PB – PersonEntity: Name: NameFull: Wells GA – PersonEntity: Name: NameFull: Verma A – PersonEntity: Name: NameFull: Joza J – PersonEntity: Name: NameFull: Nair GM – PersonEntity: Name: NameFull: Veenhuyzen G – PersonEntity: Name: NameFull: Andrade J – PersonEntity: Name: NameFull: Nault I – PersonEntity: Name: NameFull: Wong JA – PersonEntity: Name: NameFull: Sikkel M – PersonEntity: Name: NameFull: Essebag V – PersonEntity: Name: NameFull: Macle L – PersonEntity: Name: NameFull: Sapp J – PersonEntity: Name: NameFull: Roux JF – PersonEntity: Name: NameFull: Skanes A – PersonEntity: Name: NameFull: Angaran P – PersonEntity: Name: NameFull: Novak P – PersonEntity: Name: NameFull: Redfearn D – PersonEntity: Name: NameFull: Golian M – PersonEntity: Name: NameFull: Redpath CJ – PersonEntity: Name: NameFull: Sturmer M – PersonEntity: Name: NameFull: Birnie D IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: 2022 Dec Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1097-6744 Numbering: – Type: volume Value: 254 Titles: – TitleFull: American heart journal Type: main |
| ResultId | 1 |